196 related articles for article (PubMed ID: 25877150)
1. Application of Parallel Multiparametric Cell-Based FLIPR Detection Assays for the Identification of Modulators of the Muscarinic Acetylcholine Receptor 4 (M4).
Smith E; Chase P; Niswender CM; Utley TJ; Sheffler DJ; Noetzel MJ; Lamsal A; Wood MR; Conn PJ; Lindsley CW; Madoux F; Acosta M; Scampavia L; Spicer T; Hodder P
J Biomol Screen; 2015 Aug; 20(7):858-68. PubMed ID: 25877150
[TBL] [Abstract][Full Text] [Related]
2. An allosteric potentiator of M4 mAChR modulates hippocampal synaptic transmission.
Shirey JK; Xiang Z; Orton D; Brady AE; Johnson KA; Williams R; Ayala JE; Rodriguez AL; Wess J; Weaver D; Niswender CM; Conn PJ
Nat Chem Biol; 2008 Jan; 4(1):42-50. PubMed ID: 18059262
[TBL] [Abstract][Full Text] [Related]
3. Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders.
Conn PJ; Jones CK; Lindsley CW
Trends Pharmacol Sci; 2009 Mar; 30(3):148-55. PubMed ID: 19201489
[TBL] [Abstract][Full Text] [Related]
4. Detection and quantification of allosteric modulation of endogenous m4 muscarinic acetylcholine receptor using impedance-based label-free technology in a neuronal cell line.
Chen AN; Malone DT; Pabreja K; Sexton PM; Christopoulos A; Canals M
J Biomol Screen; 2015 Jun; 20(5):646-54. PubMed ID: 25534830
[TBL] [Abstract][Full Text] [Related]
5. Structure-based discovery of selective positive allosteric modulators of antagonists for the M
Korczynska M; Clark MJ; Valant C; Xu J; Moo EV; Albold S; Weiss DR; Torosyan H; Huang W; Kruse AC; Lyda BR; May LT; Baltos JA; Sexton PM; Kobilka BK; Christopoulos A; Shoichet BK; Sunahara RK
Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2419-E2428. PubMed ID: 29453275
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the novel positive allosteric modulator, LY2119620, at the muscarinic M(2) and M(4) receptors.
Croy CH; Schober DA; Xiao H; Quets A; Christopoulos A; Felder CC
Mol Pharmacol; 2014 Jul; 86(1):106-15. PubMed ID: 24807965
[TBL] [Abstract][Full Text] [Related]
7. The Muscarinic Acetylcholine Receptor M
Bender AM; Garrison AT; Lindsley CW
ACS Chem Neurosci; 2019 Mar; 10(3):1025-1034. PubMed ID: 30280567
[TBL] [Abstract][Full Text] [Related]
8. Muscarinic acetylcholine M
Liu L; Huang Y; Huang Q; Zhao Z; Yu J; Wang L
Neuropharmacology; 2017 May; 117():376-386. PubMed ID: 28257887
[TBL] [Abstract][Full Text] [Related]
9. Diverse Effects on M
Rook JM; Abe M; Cho HP; Nance KD; Luscombe VB; Adams JJ; Dickerson JW; Remke DH; Garcia-Barrantes PM; Engers DW; Engers JL; Chang S; Foster JJ; Blobaum AL; Niswender CM; Jones CK; Conn PJ; Lindsley CW
ACS Chem Neurosci; 2017 Apr; 8(4):866-883. PubMed ID: 28001356
[TBL] [Abstract][Full Text] [Related]
10. Positive allosteric modulation of M
Yohn SE; Conn PJ
Neuropharmacology; 2018 Jul; 136(Pt C):438-448. PubMed ID: 28893562
[TBL] [Abstract][Full Text] [Related]
11. Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.
Schober DA; Croy CH; Xiao H; Christopoulos A; Felder CC
Mol Pharmacol; 2014 Jul; 86(1):116-23. PubMed ID: 24807966
[TBL] [Abstract][Full Text] [Related]
12. New insight into active muscarinic receptors with the novel radioagonist [³H]iperoxo.
Schrage R; Holze J; Klöckner J; Balkow A; Klause AS; Schmitz AL; De Amici M; Kostenis E; Tränkle C; Holzgrabe U; Mohr K
Biochem Pharmacol; 2014 Aug; 90(3):307-19. PubMed ID: 24863257
[TBL] [Abstract][Full Text] [Related]
13. Current status of muscarinic M1 and M4 receptors as drug targets for neurodegenerative diseases.
Felder CC; Goldsmith PJ; Jackson K; Sanger HE; Evans DA; Mogg AJ; Broad LM
Neuropharmacology; 2018 Jul; 136(Pt C):449-458. PubMed ID: 29374561
[TBL] [Abstract][Full Text] [Related]
14. Discovery and Development of Muscarinic Acetylcholine M
Takai K; Enomoto T
Chem Pharm Bull (Tokyo); 2018; 66(1):37-44. PubMed ID: 29311510
[TBL] [Abstract][Full Text] [Related]
15. SAR studies on carboxylic acid series M(1) selective positive allosteric modulators (PAMs).
Kuduk SD; Beshore DC
Curr Top Med Chem; 2014; 14(15):1738-54. PubMed ID: 25176125
[TBL] [Abstract][Full Text] [Related]
16. Discovery of [
Tong L; Li W; Lo MM; Gao X; Wai JM; Rudd M; Tellers D; Joshi A; Zeng Z; Miller P; Salinas C; Riffel K; Haley H; Purcell M; Holahan M; Gantert L; Schubert JW; Jones K; Mulhearn J; Egbertson M; Meng Z; Hanney B; Gomez R; Harrison ST; McQuade P; Bueters T; Uslaner J; Morrow J; Thomson F; Kong J; Liao J; Selyutin O; Bao J; Hastings NB; Agrawal S; Magliaro BC; Monsma FJ; Smith MD; Risso S; Hesk D; Hostetler E; Mazzola R
J Med Chem; 2020 Mar; 63(5):2411-2425. PubMed ID: 32101422
[TBL] [Abstract][Full Text] [Related]
17. Discovery and structure-activity relationships study of positive allosteric modulators of the M
Tanaka H; Negoro K; Koike T; Tsukamoto I; Yokoyama K; Maeda J; Inagaki Y; Shimoshige Y; Ino K; Ishizu K; Takahashi T
Bioorg Med Chem; 2020 Jul; 28(13):115531. PubMed ID: 32386953
[TBL] [Abstract][Full Text] [Related]
18. Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders.
Digby GJ; Shirey JK; Conn PJ
Mol Biosyst; 2010 Aug; 6(8):1345-54. PubMed ID: 20582339
[TBL] [Abstract][Full Text] [Related]
19. Muscarinic acetylcholine receptors as CNS drug targets.
Langmead CJ; Watson J; Reavill C
Pharmacol Ther; 2008 Feb; 117(2):232-43. PubMed ID: 18082893
[TBL] [Abstract][Full Text] [Related]
20. The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors.
Betz AJ; McLaughlin PJ; Burgos M; Weber SM; Salamone JD
Psychopharmacology (Berl); 2007 Oct; 194(3):347-59. PubMed ID: 17594079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
